METHODS: A 25-question survey evaluating respondents\' management of patients status post HNRT with vocal fold paresis/paralysis was distributed to 357 otolaryngologists. Practice patterns regarding injection laryngoplasty (IL), medialization thyroplasty (MT), and arytenoid adduction (AA) were queried.
RESULTS: Eight-two clinicians (23%) completed the survey. Ninety-one percent of respondents were laryngologists, 9% head and neck surgeons, 3% comprehensive otolaryngologists, and 3% \"other.\" Eleven (15%) had been in practice <5 years, 19 (25%) for 5-10 years, and 46 (61%) for >10 years. No respondents considered HNRT a contraindication to IL, and 11 (14%) reported complications from the procedure. Hyaluronic acid (58, 75%) was most commonly injected. Twenty percent considered HNRT a contraindication to MT, and 37% considered it a contraindication to AA. Gore-Tex was used most commonly (65%). Twenty-seven percent reported major complications after MT. All complications occurred in the >10-year practice group, and this group was more likely to delay surgery after HNRT (p = 0.022). Respondents with complications were more likely to perform MT in HNRT patients (p = 0.0191).
CONCLUSIONS: Otolaryngologists generally do not consider HNRT to be a contraindication to IL, but some consider it a contraindication to MT/AA. Previous complications do not appear to deter surgeons from performing MT.
METHODS: N/A (Survey Study) Laryngoscope, 2024.
方法:对357名耳鼻喉科医师进行了一项25个问题的调查,评估了受访者对HNRT伴声带麻痹/麻痹患者状态的管理。关于注射喉成形术(IL)的实践模式,中介化甲状腺成形术(MT),并对Arytenoid内收(AA)进行了查询。
结果:八位临床医生(23%)完成了调查。91%的受访者是喉科医生,9%的头颈部外科医生,3%的综合耳鼻喉科医师,和3%“其他。“11人(15%)已经实践了<5年,19(25%)持续5-10年,和46(61%)超过10年。没有受访者认为HNRT是IL的禁忌症,11例(14%)报告手术并发症.透明质酸(58,75%)是最常见的注射。20%的人认为HNRT是MT的禁忌症,37%的人认为这是AA的禁忌症。最常用的是Gore-Tex(65%)。27%的人报告了MT后的主要并发症。所有并发症均发生在>10年实践组中,且本组患者在HNRT后延迟手术的可能性更大(p=0.022)。有并发症的受访者更有可能在HNRT患者中进行MT(p=0.0191)。
结论:耳鼻喉科医师通常不认为HNRT是IL的禁忌症,但有些人认为这是MT/AA的禁忌症。先前的并发症似乎并未阻止外科医生进行MT。
方法:N/A(调查研究)喉镜,2024.